(Q35118444)

English

Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

0 references

1 reference

based on heuristic

inferred from title

Brucella melitensis

object named as

Brucella melitensis

1 reference

based on heuristic

inferred from title

author name string

Solera J

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Rodríguez-Zapata M

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Geijo P

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Largo J

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Paulino J

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sáez L

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Martínez-Alfaro E

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sánchez L

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sepulveda MA

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ruiz-Ribó MD

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 September 1995

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2061-2067

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Possible implications of doxycycline-rifampin interaction for treatment of brucellosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

Brucellosis treated with rifampicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

In vitro susceptibility of Brucella to various antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

A comparative study of therapeutic agents used for treatment of acute brucellosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

Brucellosis in the United States, 1960-1972. An abattoir-associated disease. Part I. Clinical features and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

Human brucellosis in Kuwait: a prospective study of 400 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

Modern chemotherapy for brucellosis in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

In vitro susceptibility of Brucella melitensis to antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

Quinolones for tbe treatment of brucellosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

9 July 2018

Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

27 September 2018

[Antibiotic sensitivity of strains of Brucella]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162881

27 September 2018

Antimicrobial susceptibility of clinical isolates of Brucella

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Brucellosis: a prospective study of 100 cases]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific antibodies detected during relapse of human brucellosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The rose bengal plate agglutination test in the diagnosis of brucellosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brucellosis outbreak attributed to ingestion of umpasteurized goat cheese

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of the in vitro sensitivity of Brucella strains to rifampicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter therapeutic study of 1100 children with brucellosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of two regimens in the treatment of brucellosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Meta-analysis of the efficacy of the combination of +rifampicin and doxycycline in the treatment of human brucellosis]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxytetracycline-streptomycin therapy in brucellosis due to Brucella melitensis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of brucellosis using rifampicine (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brucellosis in a group of travelers to Spain

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of human brucellosis with rifampicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative trial of co-trimoxazole versus tetracycline-streptomycin in treating human brucellosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Effects of rifampicin on the pharmacokinetics of doxycycline]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8540716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.39.9.2061

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35118444&oldid=1773550042"